1. Home
  2. CNTA vs VVX Comparison

CNTA vs VVX Comparison

Compare CNTA & VVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CNTA
  • VVX
  • Stock Information
  • Founded
  • CNTA 2020
  • VVX 2014
  • Country
  • CNTA United Kingdom
  • VVX United States
  • Employees
  • CNTA N/A
  • VVX N/A
  • Industry
  • CNTA Biotechnology: Pharmaceutical Preparations
  • VVX Diversified Commercial Services
  • Sector
  • CNTA Health Care
  • VVX Consumer Discretionary
  • Exchange
  • CNTA Nasdaq
  • VVX Nasdaq
  • Market Cap
  • CNTA 2.0B
  • VVX 2.0B
  • IPO Year
  • CNTA 2021
  • VVX 2014
  • Fundamental
  • Price
  • CNTA $15.45
  • VVX $62.28
  • Analyst Decision
  • CNTA Strong Buy
  • VVX Buy
  • Analyst Count
  • CNTA 7
  • VVX 5
  • Target Price
  • CNTA $23.14
  • VVX $62.20
  • AVG Volume (30 Days)
  • CNTA 281.0K
  • VVX 113.3K
  • Earning Date
  • CNTA 11-15-2024
  • VVX 11-04-2024
  • Dividend Yield
  • CNTA N/A
  • VVX N/A
  • EPS Growth
  • CNTA N/A
  • VVX N/A
  • EPS
  • CNTA N/A
  • VVX N/A
  • Revenue
  • CNTA $6,853,000.00
  • VVX $4,124,560,999.00
  • Revenue This Year
  • CNTA N/A
  • VVX $8.30
  • Revenue Next Year
  • CNTA N/A
  • VVX $4.29
  • P/E Ratio
  • CNTA N/A
  • VVX N/A
  • Revenue Growth
  • CNTA N/A
  • VVX 6.92
  • 52 Week Low
  • CNTA $5.58
  • VVX $37.04
  • 52 Week High
  • CNTA $17.59
  • VVX $65.59
  • Technical
  • Relative Strength Index (RSI)
  • CNTA 49.58
  • VVX 59.46
  • Support Level
  • CNTA $14.48
  • VVX $61.39
  • Resistance Level
  • CNTA $15.69
  • VVX $63.01
  • Average True Range (ATR)
  • CNTA 0.64
  • VVX 1.33
  • MACD
  • CNTA -0.09
  • VVX -0.48
  • Stochastic Oscillator
  • CNTA 45.54
  • VVX 27.55

About CNTA Centessa Pharmaceuticals plc

Centessa Pharmaceuticals PLC is a clinical-stage pharmaceutical company. The company's pipeline assets include 1) SerpinPC for Hemophilia A, B, 2) LB101 for Solid Tumors, 3) ORX750 for Narcolepsy Type 1 (NT1) and other sleep disorders, 4) MGX292 Pulmonary Arterial Hypertension (PAH) and 5) Undisclosed for Solid Tumors.

About VVX V2X Inc.

V2X Inc is a U.S.-based company that provides services to the U.S. government. It operates as one segment and offers facility and logistics services and information technology mission support and engineering and digital integration services. The information technology and network communications capabilities consist of communications systems operations and maintenance, management and service support, systems installation and activation, system-of-systems engineering and software development, and mission support for the department of defense. The facility and logistics service include airfield management, ammunition management, civil engineering, communications, emergency services, life support activities, public works, security, transportation operations, and others.

Share on Social Networks: